Label Changes for:
Lysteda (tranexamic acid) Tablets
Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011
5 WARNINGS AND PRECAUTIONS
5.1 thromboembolic Risk
- ...Concomittant Use of Hormonal Contraceptives...
5.4 Ligneous Conjunctivitis
- section added